Begin LR - Search Results

1

Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma.

Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapdelaine A, Chevalier S. Tremblay L, et al. Among authors: begin lr. Int J Cancer. 1996 Oct 9;68(2):164-71. doi: 10.1002/(sici)1097-0215(19961009)68:2<169::aid-ijc4>3.0.co;2-w. Int J Cancer. 1996. PMID: 8900422

2

Ras p21 overexpression is a late event in prostate-cancer.

Hamdy S, Aprikian A, Begin L, Fair W, Bazinet M. Hamdy S, et al. Int J Oncol. 1994 Mar;4(3):627-31. doi: 10.3892/ijo.4.3.627. Int J Oncol. 1994. PMID: 21566969

3

Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.

Wang JC, Bégin LR, Bérubé NG, Chevalier S, Aprikian AG, Gourdeau H, Chevrette M. Wang JC, et al. Among authors: begin lr. Clin Cancer Res. 2007 Apr 15;13(8):2354-61. doi: 10.1158/1078-0432.CCR-06-1692. Epub 2007 Apr 3. Clin Cancer Res. 2007. PMID: 17406028

4

Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with Gleason score or quantity of prostate cancer in biopsy samples.

Ismail HA, Pollak M, Behlouli H, Tanguay S, Bégin LR, Aprikian AG. Ismail HA, et al. Among authors: begin lr. BJU Int. 2003 Nov;92(7):699-702. doi: 10.1046/j.1464-410x.2003.04084.x. BJU Int. 2003. PMID: 14616449 Clinical Trial.

5

Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer.

Aprikian AG, Han K, Guy L, Landry F, Begin LR, Chevalier S. Aprikian AG, et al. Among authors: begin lr. Prostate Suppl. 1998;8:52-61. Prostate Suppl. 1998. PMID: 9690664 Review. No abstract available.

6

Neuroendocrine cells of the verumontanum: a comparative immunohistochemical study.

Guy L, Bégin LR, Al-Othman K, Chevalier S, Aprikian AG. Guy L, et al. Among authors: begin lr. Br J Urol. 1998 Nov;82(5):738-43. doi: 10.1046/j.1464-410x.1998.00812.x. Br J Urol. 1998. PMID: 9839592

7

Vascular endothelial growth factor and signaling in the prostate: more than angiogenesis.

Chevalier S, Defoy I, Lacoste J, Hamel L, Guy L, Bégin LR, Aprikian AG. Chevalier S, et al. Among authors: begin lr. Mol Cell Endocrinol. 2002 Mar 28;189(1-2):169-79. doi: 10.1016/s0303-7207(01)00728-6. Mol Cell Endocrinol. 2002. PMID: 12039075

8

Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.

Landry F, Chapdelaine A, Bégin LR, Chevalier S. Landry F, et al. Among authors: begin lr. J Urol. 1996 Jan;155(1):386-90. J Urol. 1996. PMID: 7490893

9

Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.

Sircar K, Gottlieb B, Alvarado C, Aprikian A, Beitel LK, Alam-Fahmy M, Begin L, Trifiro M. Sircar K, et al. Prostate Cancer Prostatic Dis. 2007;10(4):360-8. doi: 10.1038/sj.pcan.4500967. Epub 2007 Apr 17. Prostate Cancer Prostatic Dis. 2007. PMID: 17440439

10

Monoclonal-antibody pd-41 recognizes a prostate-cancer associated antigen whose expression increases in metastases and following hormonal-therapy.

Bazinet M, Hamdy S, Begin L, Aprikian A, Fair W, Wright G. Bazinet M, et al. Int J Oncol. 1995 Dec;7(6):1421-5. doi: 10.3892/ijo.7.6.1421. Int J Oncol. 1995. PMID: 21552982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters